Mangalam Organics Ltd
Incorporated in 1981, Mangalam Organics
Ltd is a manufacturer of Camphor, Resin
and Sodium Acetate[1]
- Market Cap ₹ 455 Cr.
- Current Price ₹ 532
- High / Low ₹ 654 / 339
- Stock P/E 19.6
- Book Value ₹ 342
- Dividend Yield 0.00 %
- ROCE 7.48 %
- ROE 4.39 %
- Face Value ₹ 10.0
Pros
- Company's working capital requirements have reduced from 34.8 days to 17.1 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 7.19% over past five years.
- Company has a low return on equity of -1.19% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 375 | 338 | 491 | 493 | 494 | 530 | 559 | |
| 288 | 210 | 400 | 495 | 455 | 471 | 489 | |
| Operating Profit | 86 | 128 | 91 | -3 | 39 | 59 | 69 |
| OPM % | 23% | 38% | 19% | -1% | 8% | 11% | 12% |
| -9 | 1 | 1 | 0 | 1 | 0 | 4 | |
| Interest | 5 | 1 | 4 | 14 | 16 | 21 | 23 |
| Depreciation | 9 | 14 | 15 | 18 | 20 | 21 | 21 |
| Profit before tax | 63 | 114 | 73 | -34 | 4 | 17 | 29 |
| Tax % | 24% | 26% | 27% | -19% | -8% | 24% | |
| 48 | 85 | 54 | -27 | 4 | 13 | 23 | |
| EPS in Rs | 55.98 | 98.99 | 62.75 | -31.78 | 5.15 | 14.71 | 27.04 |
| Dividend Payout % | 2% | 2% | 2% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | 3% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -26% |
| 3 Years: | -38% |
| TTM: | 310% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 6% |
| 3 Years: | -2% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | -1% |
| Last Year: | 4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 159 | 243 | 296 | 267 | 272 | 285 |
| 20 | 24 | 212 | 190 | 173 | 272 | |
| 27 | 35 | 44 | 40 | 31 | 58 | |
| Total Liabilities | 215 | 311 | 560 | 506 | 485 | 624 |
| 102 | 121 | 198 | 227 | 244 | 269 | |
| CWIP | 3 | 0 | 8 | 1 | 5 | 26 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| 110 | 191 | 354 | 277 | 236 | 328 | |
| Total Assets | 215 | 311 | 560 | 506 | 485 | 624 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 93 | 26 | -84 | 77 | 73 | -8 | |
| -59 | -28 | -100 | -41 | -40 | -67 | |
| -36 | 2 | 183 | -36 | -33 | 74 | |
| Net Cash Flow | -2 | 0 | -1 | 1 | 1 | -1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 31 | 37 | 33 | 35 | 41 | 48 |
| Inventory Days | 113 | 314 | 321 | 201 | 164 | 285 |
| Days Payable | 20 | 71 | 43 | 35 | 28 | 63 |
| Cash Conversion Cycle | 124 | 280 | 311 | 202 | 177 | 269 |
| Working Capital Days | 72 | 110 | 109 | 56 | 31 | 17 |
| ROCE % | 50% | 20% | -4% | 4% | 7% |
Documents
Announcements
-
Closure of Trading Window
25 Sep - Closed from Oct 01, 2025 until 48 hours after results; results to be approved on or before Nov 14, 2025.
-
Voting Result And Scrutinizers Report
18 Sep - 43rd AGM on 16-Sep-2025 — eight resolutions passed; MD and executive chairman reappointments; voting results enclosed.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On September 17, 2025 For Considering The Proposal Of Raising Fund
17 Sep - Cancelled INR 60 crore NCD proposal; executed INR 50 crore Yes Bank loan on Sep 17, 2025.
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
16 Sep - AGM Sep 16, 2025: financials adopted; MD/Chairman reappointed five years; material RPTs approved; routine resolutions.
-
Update on board meeting
13 Sep - Board meeting on September 17, 2025 to consider fund raising; trading window closed from Sept 12.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Aug 2025TranscriptNotesPPT
-
Aug 2025TranscriptNotesPPT
-
May 2025TranscriptNotesPPT
-
Feb 2025TranscriptNotesPPT
-
Nov 2024TranscriptNotesPPT
-
Jul 2024TranscriptNotesPPT
-
May 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Jan 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Oct 2021TranscriptNotesPPT
-
Jul 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Jan 2021TranscriptNotesPPT
-
Oct 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
Business Overview:[1][2]
MOL is the world's largest manufacturer
of Camphor. It is an ISO 9001 /14001
/OHSAS 18001 Certified manufacturer
of Pine Chemicals such as Terpene, Synthetic Resins, etc. Company also has retail operations which include homecare and personal care products under the brand names CamPure and Mangalam